InspireMD Inc NSPR
News
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
InspireMD Reports Second Quarter 2026 Financial Results
InspireMD to Announce Second Quarter 2026 Financial Results
FDA Approves InspireMD's Application to Initiate Study of Neuro Protection System — Update
InspireMD Withdraws Guidance, Recalls CGuard Prime

